Skip to main content
Log in

Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site

  • Non-Lectin Papers
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Human blood coagulation factor X has two N-linked oligosaccharides at Asn39 and Asn49 residues and two O-linked oligosaccharides at Thr17 and Thr29 residues in the region of the factorX activationpeptide (XAP) which is cleaved off during its activation by factor IXa. We determined the structure of oligosaccharides in the XAP region of human factor X. Four glycopeptides each containing a glycosylation site were isolated by digestion of XAP with endoproteinase Asp-N followed by reversed-phase HPLC. N-linked oligosaccharides released from the glycopeptides by glycoamidase A digestion were derivatized with 2-aminopyridine. Pyridylamino(PA)-oligosaccharides were separated by HPLC into neutral and sialyl oligosaccharides using an anion-exchange column. Structures of oligosaccharides and their contents at each glycosylation site were determined by a two-dimensional sugar mapping method. The contents of the neutral oligosaccharides at Asn39 and Asn49 residues were 32.5% and 30.0%, respectively. Six neutral and twelve monosialyl oligosaccharides isolated from both N-linked glycosylation sites showed similar elution profiles composed of bi-, tri-and tetra-antennary complex type oligosaccharides. The predominant component in neutral oligosaccharides was biantennary without a fucose residue. Two major monosialyl oligosaccharides were also biantennary without fucose and with a Neu5Acα-2→6 residue. In addition, the structures of O-linked oligosaccharides at Thr17 and Thr29 residues were suggested to be disialylated Gal/β3GalNAc sequences by their component analyses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Gal:

d-galactose

GlcNAc:

N-acetyl-d-glucosamine

Man:

d-mannose

HPLC:

high-performance liquid chromatography

NDV:

Newcastle disease virus

Neu5Ac:

5-N-acetylneuraminic acid

ODS:

octadecylsilyl

PA:

pyridylamino

RVV-X:

Russell's viper venom factor X activator

TBS:

Tris-buffered saline

XAP:

factor X activation peptide.

References

  1. DiScipo RG, Hermodson MA, Davie EW (1977)Biochemistry 16: 5253–60.

    Google Scholar 

  2. Steinberg M, Nemerson Y (1982)The activation of factor X in Hemostasis and Thrombosis (Colman RW, Hirsh J Marder VJ, Salzman EW eds) pp. 91–99. Philadelphia PA: JB Lippincott.

    Google Scholar 

  3. Fenton JW (1988)Thromb Hemostasis 14:234–40.

    Google Scholar 

  4. Jamieson GA (1988)Prog Clin Biol Res 283:137–58.

    Google Scholar 

  5. Goligorsky MS, Menton DN, Laszlo A, Lum H (1990)J Biol Chem 264:16771–75.

    Google Scholar 

  6. Iino M, Takeya H, Nishioka J, Suzuki K (1994)J Biochem (Tokyo)116:335–40.

    Google Scholar 

  7. Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW (1984)Proc Natl Acad Sci USA 81: 3699–702.

    Google Scholar 

  8. Inoue K, Morita T (1993)Eur J Biochem 218: 153–63.

    Google Scholar 

  9. Sinha U, Wolf DL (1993)J Biol Chem 268: 3048–51.

    Google Scholar 

  10. Tomiya N, Awaya J, Kurono M, Endo S, Arata Y, Takahashi N (1988)Anal Biochem 171: 73–90.

    Google Scholar 

  11. Takahashi N, Tomiya N (1992)Handbook of Endoglycosidases and Glycoamidases (Takahashi N, Muramatsu T eds) pp. 199–332. Boca Raton FL: CRC Press.

    Google Scholar 

  12. Tsuda E, Goto M, Murakami A, Akai K, Ueda M, Kawannishi G, Takahashi N, Sasaki R, Chiba H, Ishihara H, Mori M, Tejima S, Endo S, Arata Y (1988)Biochemistry 27: 5646–54.

    Google Scholar 

  13. Takeya H, Nishida S, Miyata T, Kawada S, Saisaka Y, Morita T, Iwanaga S (1992)J Biol Chem 267: 14109–17.

    Google Scholar 

  14. Miletich JP, Broze GJ, Majerus PW (1980)Anal Biochem 105: 304–10.

    Google Scholar 

  15. Morita T, Kisiel W (1985)Biochem Biophys Res Commun 130: 841–47.

    Google Scholar 

  16. Tomiya N, Kurono M, Ishihara H, Tejima S, Endo S, Arata Y, Takahashi N (1987)Anal Biochem 163: 489–99.

    Google Scholar 

  17. Hase S, Ikenaka T, Matsushima Y (1978)Biochem Biophys Res Commun 85: 257–63.

    Google Scholar 

  18. Yamamoto S, Hase S, Fukuda S, Sano O, Ikenaka T (1989)J Biochem 105: 547–55.

    Google Scholar 

  19. Takahashi N, Wada Y, Awaya J, Kurono M, Tomiya N (1993)Anal Biochem 208: 96–109.

    Google Scholar 

  20. Jefferis R, Lund J, Mizutani H, Nakagawa H, Kawazoe Y, Arata Y, Takahashi N (1990)Biochem J 268: 529–37

    Google Scholar 

  21. Paulson JC, Weinstein J, Dorland L, van Halbeek H, Vliegenthart JFG (1982)J Biol Chem 257: 12734–38.

    Google Scholar 

  22. Hardy MR, Townsend RR, Lee YC (1988)Anal Biochem 170: 54–62.

    Google Scholar 

  23. Lee YC (1990)Anal Biochem 189: 151–62.

    Google Scholar 

  24. Hase S (1993)Glycoprotein Analysis in Biomedicine (Hounsell EF eds) pp. 69–80. Totowa NJ: Humana Press.

    Google Scholar 

  25. Mizuochi T, Yamashita K, Fujikawa K, Titani K, Kobata A (1980)J Biol Chem 255: 3526–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakagawa, H., Takahashi, N., Fujikawa, K. et al. Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. Glycoconjugate J 12, 173–181 (1995). https://doi.org/10.1007/BF00731362

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00731362

Keywords

Navigation